HomeRYTM • NASDAQ
add
Rhythm Pharmaceuticals Inc
Previous close
$38.15
Day range
$37.36 - $38.89
Year range
$15.50 - $52.57
Market cap
2.36B USD
Avg Volume
569.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 24.23M | 175.70% |
Operating expense | 62.27M | 24.87% |
Net income | -41.63M | 2.02% |
Net profit margin | -171.80 | 64.46% |
Earnings per share | -0.70 | 5.41% |
EBITDA | -40.85M | 1.95% |
Effective tax rate | -0.47% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 275.85M | -17.23% |
Total assets | 332.74M | -13.00% |
Total liabilities | 162.99M | 37.87% |
Total equity | 169.76M | — |
Shares outstanding | 60.14M | — |
Price to book | 13.34 | — |
Return on assets | -30.03% | — |
Return on capital | -43.34% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -41.63M | 2.02% |
Cash from operations | -29.38M | 13.58% |
Cash from investing | 22.64M | 155.52% |
Cash from financing | 2.42M | -86.05% |
Net change in cash | -4.51M | 92.14% |
Free cash flow | -16.99M | 24.99% |
About
Founded
Nov 2008
Headquarters
Website
Employees
226